Perspectives
AMCP 2024: Behind the research with Jacob LaRue and Timothy O’Shea
Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty drugs without therapeutic impact to patients
April 16, 2024It’s day one of the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting 2024 in New Orleans, and the energy inside the Ernest N. Morial Convention Center is high as leaders from across the health care space — including Prime Therapeutics/MagellanRx Management (Prime/MRx) — tackle some of the most pressing issues facing the industry.
A key factor driving health care spend today is high-cost specialty drugs, which are often used to treat severe diseases and conditions. That was the focus of the day-one session, “You Can Round That! Establishing and Managing Mandatory Drug Wastage Programs,” featuring Jacob LaRue, assistant vice president of specialty clinical solutions at Prime/MRx, and Timothy O’Shea, manager of clinical pharmacy at Horizon Blue Cross Blue Shield of New Jersey.
We caught up with Jacob and Timothy earlier today to hear how Prime/MRx is working alongside providers, like Horizon Blue Cross Blue Shield of New Jersey, to manage drug waste and rein in spend for specialty drugs without therapeutic impact to patients.
Stay tuned for additional coverage from AMCP Annual 2024 on our newsroom, and follow us on LinkedIn or X (formerly Twitter).
Related news
Perspectives
April 25, 2024
Clinical News: April 2024
Your monthly source for drug information highlights
Perspectives
April 25, 2024
Drug Approvals Monthly Update: April 2024
This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals…
Perspectives
April 25, 2024
Drug Approvals Quarterly Update: April 2024
This wrap-up provides a review of newly approved drugs, recent drug launches, new…